Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference

Rhea-AI Summary

Castle Biosciences (NASDAQ: CSTL), a healthcare company focused on innovative diagnostic testing, has announced its participation in the upcoming 2025 Jefferies Global Healthcare Conference. The company's executive management will deliver a corporate presentation on Wednesday, June 4, 2025, at 7:35 a.m. Eastern time. Investors and interested parties can access the live audio webcast through Castle Biosciences' investor relations website, with a replay available after the presentation.

FRIENDSWOOD, Texas, May 21, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the 2025 Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 7:35 a.m. Eastern time.

A live audio webcast of the Company’s presentation will be available by visiting Castle Biosciences’ website at https://ir.castlebiosciences.com/events-presentations/default.aspx. A replay of the webcast will be available following the conclusion of the live broadcast.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com

Source: Castle Biosciences Inc.

FAQ

When is Castle Biosciences (CSTL) presenting at the 2025 Jefferies Healthcare Conference?

Castle Biosciences will present at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 7:35 a.m. Eastern time.

How can I watch Castle Biosciences' (CSTL) presentation at the Jefferies Conference?

The presentation can be accessed via live audio webcast on Castle Biosciences' website at ir.castlebiosciences.com under the Events & Presentations section. A replay will be available after the presentation.

What does Castle Biosciences (CSTL) do as a company?

Castle Biosciences is a healthcare company that develops and provides innovative tests designed to guide patient care.